A detailed history of Traphagen Investment Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 33,271 shares of PFE stock, worth $923,602. This represents 0.11% of its overall portfolio holdings.

Number of Shares
33,271
Previous 32,948 0.98%
Holding current value
$923,602
Previous $921,000 4.45%
% of portfolio
0.11%
Previous 0.11%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$27.7 - $31.39 $8,947 - $10,138
323 Added 0.98%
33,271 $962,000
Q2 2024

Jul 23, 2024

SELL
$25.26 - $29.6 $2,879 - $3,374
-114 Reduced 0.34%
32,948 $921,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $855,975 - $982,933
33,062 New
33,062 $917 Million
Q4 2023

Jun 17, 2024

BUY
$26.13 - $33.94 $125,842 - $163,455
4,816 Added 14.57%
37,878 $1.09 Billion
Q3 2023

Jun 17, 2024

BUY
$32.09 - $37.51 $111,737 - $130,609
3,482 Added 10.53%
36,544 $1.21 Billion
Q2 2023

Jun 17, 2024

BUY
$36.12 - $41.79 $267,974 - $310,040
7,419 Added 22.44%
40,481 $1.48 Billion
Q1 2023

Jun 17, 2024

SELL
$39.39 - $51.28 $86,500 - $112,610
-2,196 Reduced 5.16%
40,332 $1.65 Billion
Q4 2022

Jun 17, 2024

BUY
$41.75 - $54.5 $395,205 - $515,897
9,466 Added 28.63%
42,528 $2.18 Billion
Q3 2022

Jun 17, 2024

SELL
$43.76 - $53.42 $5,601 - $6,837
-128 Reduced 0.3%
42,753 $1.87 Billion
Q2 2022

Jun 17, 2024

BUY
$46.53 - $55.17 $456,878 - $541,714
9,819 Added 29.7%
42,881 $2.25 Billion
Q1 2022

Jun 17, 2024

BUY
$45.75 - $56.69 $134,596 - $166,781
2,942 Added 7.81%
40,631 $2.1 Billion
Q4 2021

Jun 17, 2024

BUY
$41.32 - $61.25 $191,187 - $283,403
4,627 Added 13.99%
37,689 $2.23 Billion
Q3 2021

Jun 17, 2024

BUY
$39.25 - $50.42 $12,246 - $15,731
312 Added 0.86%
36,463 $1.57 Billion
Q2 2021

Jun 17, 2024

SELL
$35.91 - $40.68 $44,887 - $50,850
-1,250 Reduced 3.34%
36,151 $1.42 Billion
Q1 2021

Jun 17, 2024

BUY
$33.49 - $37.77 $145,313 - $163,884
4,339 Added 13.12%
37,401 $1.36 Billion
Q4 2020

Jun 17, 2024

SELL
$33.47 - $42.56 $121,897 - $155,003
-3,642 Reduced 8.83%
37,604 $1.38 Billion
Q3 2020

Jun 17, 2024

SELL
$31.75 - $37.25 $26,733 - $31,364
-842 Reduced 2.0%
41,246 $1.51 Billion
Q2 2020

Jun 17, 2024

BUY
$30.12 - $36.54 $271,863 - $329,810
9,026 Added 27.3%
42,088 $1.38 Billion
Q1 2020

Jun 17, 2024

BUY
$27.03 - $38.62 $277,057 - $395,855
10,250 Added 31.0%
43,312 $1.41 Billion
Q4 2019

Jun 17, 2024

BUY
$32.92 - $37.36 $249,961 - $283,674
7,593 Added 22.97%
40,655 $1.59 Billion
Q3 2019

Jun 17, 2024

BUY
$32.49 - $42.13 $8,674 - $11,248
267 Added 0.81%
33,329 $1.2 Billion
Q2 2019

Jun 17, 2024

SELL
$36.98 - $41.52 $117,078 - $131,452
-3,166 Reduced 9.58%
29,896 $1.3 Billion
Q1 2019

Jun 17, 2024

SELL
$37.5 - $41.2 $119,212 - $130,974
-3,179 Reduced 9.62%
29,883 $1.27 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Traphagen Investment Advisors LLC Portfolio

Follow Traphagen Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.